EB-2 NIW获批案例解析:柔性可穿戴电子博士后Dr. Z,RFE仅涉两项文件问题即获批准 EB-2 NIW Approval Case Analysis: Dr. Z, a Postdoc in Flexible and Wearable Electronics, Approved After an RFE Limited to Two Documentation Issues
一句话核心总结(TL;DR):Dr. Z是美国某研究型大学的博士后研究学者,拥有电子科学与技术博士学位,研究方向为透气、可拉伸的柔性电子与可穿戴生物医学传感。其EB-2 NIW国家利益豁免申请于2025年8月1日被USCIS接收,加急处理后于2026年5月27日收到RFE,但RFE仅涉及两项文件问题(说明拟采用的身份调整程序、提供中国专利的认证英文翻译),USCIS明确表示Dhanasar三要素无需补充证据。回复后,I-140于2026年8月26日获批,保留2025年8月1日的优先日(Priority Date)。关键结论:清晰的拟议事业、持续的科研记录(初次递交时至少903次Google Scholar引用)、顶刊独立引用与专家推荐信相互印证,是本案在实质要件上获得认可的核心;同时,完整的辅助文件同样重要。I-140获批不等于获得绿卡。
TL;DR (English): Dr. Z, a Postdoctoral Research Scholar at a U.S. research university with a Ph.D. in Electronic Science and Technology, works on breathable, stretchable flexible electronics and wearable biomedical sensing. The EB-2 NIW petition was received by USCIS on August 1, 2025. After premium processing was requested, USCIS issued an RFE on May 27, 2026 that was limited to two documentation matters (clarifying the intended adjustment-of-status process and providing a certified English translation of a Chinese patent), and stated that no further evidence was required on the three Dhanasar elements. After the response, the I-140 was approved on August 26, 2026, retaining the August 1, 2025 priority date. Key takeaway: a coherent proposed endeavor, a sustained research record (at least 903 Google Scholar citations at filing), independent recognition in leading journals, and expert letters reinforced each other on the merits, while complete supporting documents remained essential. I-140 approval is not the grant of permanent residence.
新未名律所立足美国首都华盛顿地区,长期为大华府DMV地区、马里兰(Maryland)、弗吉尼亚(Virginia)及全美的华人、留学生、博士后及高科技/科研人员办理NIW国家利益豁免、EB-1A、EB-2/3 PERM等职业移民。本文由本所高级技术专员Wei Wang提供案例,以中英双语解析Dr. Z的EB-2 NIW获批过程,供正在准备NIW的博士后和科研人员参考。
New Weiming Law Group is based in the Washington D.C. metropolitan area and has long represented Chinese nationals, international students, postdocs, and STEM professionals in the DMV region, Maryland, Virginia, and nationwide in NIW, EB-1A, and EB-2/3 PERM employment-based immigration. This case was provided by Wei Wang, Senior Technology Specialist, and presents a bilingual analysis of Dr. Z's EB-2 NIW approval for postdocs and researchers preparing their own petitions.
1. Dr. Z的学术背景和拟议事业(Proposed Endeavor)是什么?
What Were Dr. Z's Academic Background and Proposed Endeavor?
Dr. Z拥有电子科学与技术博士学位,专攻有机电子、柔性电子材料和可穿戴生物医学器件。递交NIW时,Dr. Z在美国一所研究型大学担任博士后研究学者。拟议事业的核心是推进透气、可拉伸电子器件和高性能传感系统,应用于健康监测、生物医学工程、人机交互和先进电子技术。
Dr. Z holds a Ph.D. in Electronic Science and Technology, specializing in organic electronics, flexible electronic materials, and wearable biomedical devices. At filing, Dr. Z was a Postdoctoral Research Scholar at a U.S. research university. The proposed endeavor centered on advancing breathable, stretchable electronics and high-performance sensing systems for health monitoring, biomedical engineering, human–machine interfaces, and advanced electronic technologies.
2. Dr. Z有哪些原创贡献和独立学术影响力?
What Original Contributions and Independent Scientific Impact Did Dr. Z Show?
Dr. Z开发了透气性表皮电子、多孔透明电极、金属网格应变传感器以及柔性器件导电材料等技术。这些研究针对器件透气性、可拉伸性、透明度和与人体可靠贴合等实际技术障碍,有助于开发更舒适、更耐用的可穿戴传感器和下一代生物电子系统。
Dr. Z developed technologies involving gas-permeable epidermal electronics, porous transparent electrodes, metal-mesh strain sensors, and conductive materials for flexible devices. This work addresses practical barriers such as breathability, stretchability, transparency, and reliable contact with the human body, supporting more comfortable and durable wearable sensors and next-generation bioelectronic systems.
| 证据类别 / Evidence | 具体内容 / Details |
|---|---|
| 同行评审论文 Peer-reviewed publications |
ACS Nano、ACS Applied Materials & Interfaces、Nano Research、Nano Energy、Advanced Materials Technologies等期刊 ACS Nano, ACS Applied Materials & Interfaces, Nano Research, Nano Energy, Advanced Materials Technologies, and others |
| 引用记录 Citations |
初次递交时至少903次Google Scholar引用;补充报告显示截至2026年8月达1,013次 At least 903 Google Scholar citations at filing; 1,013 as of August 2026 per a supplemental report |
| 代表作 Signature paper |
2020年第一作者ACS Nano论文,主题为透气、超薄、可拉伸表皮电子,原始申请时约270次引用 First-authored 2020 ACS Nano paper on gas-permeable, ultrathin, stretchable epidermal electronics, about 270 citations at filing |
| 专利 Patent |
一项关于透气、超薄、可拉伸表皮电子器件的美国专利申请 A U.S. patent application on gas-permeable, ultrathin, stretchable epidermal electronic devices |
| 推荐信与审稿 Letters and peer review |
四封来自美国及海外大学学者的独立专家推荐信,以及有记录的期刊审稿经历 Four independent expert letters from U.S. and international scholars, plus documented journal peer-review service |
🔬 实质性独立认可:发表在PNAS(美国国家科学院院刊)和Chemical Reviews上的文章讨论了Dr. Z的透气电极工作;Nature Nanotechnology和Science Advances上也有引用其成果的论文。这类独立引用说明其工作正被更广泛的学术界关注和使用,而不只是"引用数字"。
Substantive independent recognition: Articles in Proceedings of the National Academy of Sciences and Chemical Reviews discussed Dr. Z's gas-permeable electrode work, and citing papers appeared in Nature Nanotechnology and Science Advances. These independent references show the work is being noticed and used in the broader literature, beyond raw citation counts.
3. Dr. Z如何满足Matter of Dhanasar的NIW三要素?
How Did Dr. Z Satisfy the Three Prongs of Matter of Dhanasar?
第一要素:实质价值与国家重要性
Prong One: Substantial Merit and National Importance
可穿戴生物医学传感和柔性电子研究具有实质性的科学与技术价值。申请书将透气电子界面和传感系统的进展与医疗健康、先进制造和人机交互等更广泛领域的潜在收益相联系,而不局限于某一雇主的业务。
Research in wearable biomedical sensing and flexible electronics has substantial scientific and technological merit. The petition linked breathable electronic interfaces and sensing systems to broader benefits in healthcare, advanced manufacturing, and human–machine interaction, rather than to a single employer's activities.
第二要素:具备推进该事业的良好条件
Prong Two: Well Positioned to Advance the Endeavor
博士学位、专业研究经验、持续的美国博士后职位、发表记录、独立引用、专家推荐信、专利相关工作和审稿活动,构成相互印证的证据,证明其有能力继续推进这一研究。
The doctorate, specialized research experience, ongoing U.S. postdoctoral appointment, publications, independent citations, expert letters, patent-related work, and peer review together provided mutually reinforcing evidence of capacity to continue the research.
第三要素:豁免工作邀约与劳工证(PERM)对美国有益
Prong Three: Benefit of Waiving the Job Offer and Labor Certification
申请书论证,Dr. Z的跨学科研究和专业能力可在学术机构和产业界推动美国创新;拟议工作并不局限于某一个固定职位,在综合权衡下支持豁免要求。
The petition argued that Dr. Z's interdisciplinary research and specialized capabilities could advance U.S. innovation across institutional and industrial settings. The work was not confined to one permanent job opening, supporting the waiver under the overall balancing analysis.
4. 本案的递交、RFE与批准时间线是怎样的?
What Was the Filing, RFE, and Approval Timeline?
| 日期 / Date | 事件 / Event |
|---|---|
| 2025年8月1日 August 1, 2025 |
USCIS接收EB-2 NIW I-140申请(即优先日) USCIS received the EB-2 NIW I-140 petition (priority date) |
| 之后 Subsequently |
申请加急处理(Premium Processing) Premium processing requested |
| 2026年5月27日 May 27, 2026 |
USCIS发出RFE,仅涉及两项文件问题 USCIS issued an RFE limited to two documentation matters |
| 2026年8月26日 August 26, 2026 |
✅ EB-2 NIW I-140获批,保留2025年8月1日优先日 EB-2 NIW I-140 approved, retaining the August 1, 2025 priority date |
5. 本案RFE只涉及两项文件问题,说明了什么?
What Does an RFE Limited to Two Documentation Issues Tell Us?
RFE仅要求两项内容:说明拟采用的身份调整(I-485)程序,以及提供一项中国专利的认证英文翻译。USCIS同时表示,当时无需就Dhanasar三要素提交更多证据。这说明申请书在实质要件上已较为充分;但即便如此,辅助文件不完整同样会触发RFE、拉长审理时间。外文文件应附完整的认证英文翻译,后续身份调整或领事程序的计划也应在递交前梳理清楚。
The RFE asked only for clarification of the intended adjustment-of-status (I-485) process and a certified English translation of a Chinese patent. USCIS also stated that no further evidence was required at that time on the three Dhanasar elements. This indicates the petition was strong on the merits, yet incomplete supporting documents can still trigger an RFE and extend processing. Foreign-language documents should include complete certified translations, and the plan for adjustment or consular processing should be clear before filing.
6. I-140获批是否等于拿到绿卡?
Does I-140 Approval Mean You Have a Green Card?
不是。I-140获批确立的是移民申请(immigrant petition)获得批准,并不等于获得永久居民身份。申请人仍需在优先日排期允许时,通过I-485身份调整或海外领事程序完成绿卡申请;排期取决于出生国别和美国国务院Visa Bulletin。在此期间,博士后、F-1、J-1或H-1B持有人应同步维护好现有非移民身份,J-1持有人还需关注是否涉及J-1两年回国要求及豁免。
No. I-140 approval establishes approval of the immigrant petition, not the grant of permanent resident status. The applicant must still complete the green card process through I-485 adjustment of status or consular processing once the priority date is current, which depends on country of chargeability and the State Department Visa Bulletin. Meanwhile, postdocs on F-1, J-1, or H-1B status should keep their nonimmigrant status valid, and J-1 holders should check whether the two-year home residency requirement and a J-1 waiver apply.
7. 本案对博士后和科研人员申请NIW有什么启示?
What Lessons Does This Case Offer Postdocs and Researchers Applying for NIW?
- 拟议事业要清晰连贯:把具体研究与美国在医疗、制造、技术创新上的更广泛利益联系起来,而不只是描述当前职位。
Present a coherent endeavor that links specific research to broader U.S. benefits in healthcare, manufacturing, and innovation, not just the current job. - 证明持续的科研记录:论文、引用、专利和审稿应形成连续轨迹,并可在审理期间补充更新数据。
Show a sustained record — publications, citations, patents, and peer review — and update data during adjudication when helpful. - 突出实质性独立认可:顶刊中对你工作的具体讨论,往往比单纯的引用数字更有说服力。
Highlight substantive independent recognition; specific discussion of your work in leading journals often persuades more than raw counts. - 辅助文件要完整:外文材料的认证翻译、后续身份调整计划等细节,都可能影响审理效率。
Keep supporting documents complete; certified translations and the adjustment plan can affect processing efficiency.
新未名律所的靠谱华人移民律师团队与技术专员协作,深入理解申请人的科研内容,长期办理NIW国家利益豁免、EB-1A杰出人才、EB-1B杰出研究员、EB-2/3 PERM、I-140/I-485、RFE回复、优先日(Priority Date)策略,以及H-1B、L-1、O-1、F-1身份维护、J-1豁免和双重意图(Dual Intent)规划等各类移民和工作身份申请。如果您是博士后、研究员或高科技从业者,欢迎联系我们获取免费评估(Free Evaluation)。新未名律所在美国首都华盛顿地区、大华府DMV地区、马里兰(Maryland)和弗吉尼亚(Virginia)为华人、留学生、博士后及高科技/科研人员提供全方位移民法律服务。
New Weiming Law Group's experienced immigration attorneys work alongside technology specialists to understand each applicant's research, handling NIW, EB-1A, EB-1B, EB-2/3 PERM, I-140/I-485, RFE responses, priority date strategy, H-1B, L-1, O-1, F-1 status maintenance, J-1 waivers, and Dual Intent planning. If you are a postdoc, researcher, or technology professional, contact us for a Free Evaluation. New Weiming Law Group serves the Washington D.C. metropolitan area, the DMV region, Maryland, and Virginia, providing comprehensive immigration legal services for Chinese nationals, international students, postdocs, and STEM professionals.
关于新未名律所 / About New Weiming Law Group
新未名律所(New Weiming Law Group)成立于2009年,立足美国首都华盛顿地区,服务大华府DMV地区、马里兰(Maryland)和弗吉尼亚(Virginia)及全美的华人、留学生、博士后及高科技/科研人员。
Founded in 2009, New Weiming Law Group is based in the Washington D.C. metropolitan area and serves Chinese nationals, international students, postdocs, and STEM professionals in the DMV region, Maryland, Virginia, and nationwide.
律所精英合伙人团队均拥有美国顶级法学院法学博士(J.D.)学位,及名校理工科博士(Ph.D.)学位和多年科研经验。结合体系内美国移民律师协会(AILA)成员的专业视野与超过17年的风控博弈及一线护航经历,提供免费评估 Free Evaluation。
Our partners hold J.D. degrees from leading U.S. law schools as well as Ph.D. degrees in STEM fields from top universities, with years of research experience. Combining the professional perspective of AILA members with more than 17 years of front-line risk management and case advocacy, we provide a Free Evaluation.
官网 / Website:www.nwmlaw.com
邮箱 / Email:info@nwmlaw.com
关于"新未名"名称及机构关系的澄清说明
美国新未名律师事务所(New Weiming Law Group, PLLC)系在美国依法设立并执业的律师事务所,从2009年创立至今,已经帮助上万申请人取得了美国绿卡、签证和各类移民申请批准。本所在中国大陆没有设立任何分所、分支机构、办事处、代表处或其他经营机构。
对于在中国境内注册或者经营、名称中含有"新未名"字样的出国服务、移民服务、留学服务、中介、咨询或其他机构,本所特此说明:这些机构不是美国新未名律师事务所的中国分所、分支机构或办事处,与本所不存在隶属、控股、加盟、合伙、共同经营或授权代理关系。
如有任何个人或机构声称其为美国新未名律师事务所在中国的分所、办公室、代表处、独家代理或授权机构,请直接发信向美国新未名律师事务所核实。
核实邮箱 / Verification Email:info@nwmlaw.com
美国新未名律师事务所
New Weiming Law Group, PLLC
Clarification Regarding the "New Weiming" Name and Institutional Relationships (English Translation)
New Weiming Law Group, PLLC is a law firm lawfully established and practicing in the United States. Since its founding in 2009, it has helped tens of thousands of applicants obtain approvals for U.S. green cards, visas, and other immigration applications. The firm has not established any branch office, subsidiary, office, representative office, or other business establishment in mainland China.
With respect to overseas services, immigration services, study-abroad services, agencies, consultancies, or other organizations registered or operating in China whose names contain the words "新未名" (New Weiming), the firm hereby states: these organizations are not branches, subsidiaries, or offices of New Weiming Law Group in China, and have no affiliation, controlling interest, franchise, partnership, joint operation, or authorized agency relationship with the firm.
If any individual or organization claims to be a branch, office, representative office, exclusive agent, or authorized entity of New Weiming Law Group in China, please verify directly with New Weiming Law Group by email.
New Weiming Law Group, PLLC
免责声明:本文仅为一般性法律信息介绍,不针对任何个人案件构成法律意见,也不构成对审批或案件结果的保证。本案已隐去申请人身份信息,案例结果取决于具体事实和证据,过往案件结果不保证未来结果。I-140获批不等于获得永久居民身份。USCIS审查标准、处理时间和排期可能随时变化,请以官方最新发布为准。请咨询合格的美国移民律师。
Disclaimer: This article provides general legal information only. It does not constitute legal advice for any specific case and does not guarantee any approval or outcome. The applicant's identity has been anonymized; results depend on specific facts and evidence, and past results do not guarantee future outcomes. I-140 approval is not the grant of permanent resident status. USCIS standards, processing times, and visa availability may change at any time; rely on the latest official sources. Consult a qualified U.S. immigration attorney.